黑料正能量

India Diagnostic Imaging Equipment Market Trends and Insights

Rise in Chronic Diseases

Diabetes now affects 11.4% of Indian adults, while hypertension touches 35.5%, and cancer incidence is forecast to increase to 549 per 100,000 inhabitants by 2031.^{[2]Source: Ranjit Mohan Anjana et al., 鈥淢etabolic non-communicable disease health report of India,鈥� thelancet.com} These numbers translate into sustained need for CT angiography, multiphase MRI, and PET-CT workflows capable of detecting early lesions and monitoring therapy response. Providers are shifting from single-modality rooms to integrated suites that streamline oncologic and cardiometabolic pathways, accelerating capital expenditure on high-slice CT and 3 T MRI. Gender-specific imaging protocols are emerging as women above 60 years show higher non-communicable disease prevalence, influencing scanner throughput planning and coil inventory. The chronic disease surge is therefore rewiring procurement decisions across the India diagnostic imaging equipment market.

Growing Geriatric Population

The number of Indians aged 60 years and above is climbing steadily, with higher life expectancy concentrated in southern and western states. Age-related musculoskeletal degeneration, neuro-degenerative conditions, and cardiovascular remodeling demand low-dose, comfort-optimized imaging systems. Hospitals are adding dual-energy X-ray absorptiometry, low-contrast cardiac CT, and silent MRI sequences to accommodate frail patients who may not tolerate lengthy procedures. In turn, vendors emphasize patient-centric ergonomics such as wide bores, noise-reduction software, and automated positioning, hallmarks now critical to competing in the India diagnostic imaging equipment market.

AI-Enabled and Advanced Imaging Adoption

GE HealthCare鈥檚 collaborations with NVIDIA and AWS to embed autonomous acquisition and cloud-based analytics into X-ray, ultrasound, and MRI systems exemplify the rapid digitization of radiology workflows. Siemens Healthineers鈥� MAGNETOM Flow platform reduces helium usage by 90% and integrates deep-learning reconstruction algorithms, lowering lifetime operating costs while boosting image clarity. The upgrade cycle initially unfolds in metros but quickly tracks along established referral corridors into Tier-2 cities as payors expand coverage for AI-assisted modalities. Handheld ultrasound devices such as Vscan Air already demonstrate 99.11% sensitivity for pediatric pneumonia versus 69.8% for chest radiography, catalyzing point-of-care adoption.

Insurance Expansion & PPP Programs

Ayushman Bharat PM-JAY received INR 9,406 crore in 2025, widening coverage for advanced imaging in secondary and tertiary care. Parallel PPP contracts bring multi-slice CT and 1.5 T MRI scanners into district hospitals, while a standardized fee schedule guarantees predictable reimbursement for private partners. The dedicated INR 4,200 crore Health Infrastructure Mission budget earmarks imaging purchases, enabling district-level hubs to service cluster facilities via hub-and-spoke teleradiology. As insurers ratify AI-based reporting, previously discretionary imaging procedures migrate into reimbursable categories, solidifying demand across the India diagnostic imaging equipment market.

High Equipment & Procedure Costs

Capital intensity remains a formidable hurdle as MRI and CT scanners can consume 20-25% of a mid-size hospital鈥檚 equipment budget. Smaller facilities rely on a USD 180 million secondary market for pre-owned units, which now equals 10% of overall medical equipment trade. Stakeholders continue to lobby for GST cuts on X-ray and diagnostic kits, arguing that a lower tax slab would widen adoption.^{[3]Source: Medical Buyer, 鈥淚ndustry call for rationalizing GST on diagnostic kits, x-ray equipment,鈥� medicalbuyer.co.in} Indigenous MRI prototypes priced 30-50% below imports promise relief, but scale-up hinges on validated clinical performance and after-sales networks, factors that still temper diffusion in the India diagnostic imaging equipment market.

Shortage of Skilled Radiologists & Technicians

India has almost doubled its medical colleges in a decade, yet sub-specialty radiology seats remain limited, perpetuating a mismatch between equipment availability and interpretive capacity. Vacancy rates are especially acute in North and East India, where imaging volumes outpace trained manpower. Teleradiology bridges gaps but relies on reliable broadband, often absent in rural belts. Vendors are embedding AI triage tools that flag critical findings, but regulatory approval for fully autonomous reads is still evolving. The workforce deficit therefore constrains throughput and return on investment for high-end devices, moderating growth of the India diagnostic imaging equipment market.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Modality: X-Ray Dominance Amid CT Innovation

X-ray systems retained 28.74% share of the India diagnostic imaging equipment market in 2025 thanks to ubiquity in emergency and primary care. Computed tomography, however, is projected to post the fastest 8.62% CAGR as cardiac calcium scoring, trauma imaging, and oncology staging protocols proliferate in secondary and tertiary centers. Digital radiography upgrades, driven by lower detector prices and sharper images, are rapidly supplanting analog systems, while AI algorithms now automate fracture detection and tuberculosis screening. High-field MRI installations are also climbing, aided by domestic 1.5 T prototypes slated for clinical validation at AIIMS Delhi, which could shrink scan fees by over 30% and amplify the India diagnostic imaging equipment market size within the segment.

CT vendors increasingly bundle spectral imaging, metal-artifact reduction, and remote service diagnostics, reducing downtime and improving cost-per-study economics. Nuclear medicine retains a niche footprint confined to tertiary oncology hubs, yet PET-CT demand rises as precision oncology gains traction. Ultrasound remains the modality of choice for obstetrics, gastroenterology, and emergency evaluations, but handheld probes are gaining ground in out-of-hospital care. Overall, modality mix evolution underscores how technological sophistication and affordability now co-determine capital budgets across the India diagnostic imaging equipment market.

By Portability: Fixed Systems Lead, Mobile Solutions Accelerate

Fixed installations accounted for 82.05% of the India diagnostic imaging equipment market size in 2025, reflecting decades-old infrastructure geared to inpatient imaging and trauma care. Yet mobile and handheld devices are escalating at an 7.86% CAGR, buoyed by government vans serving rural districts and corporate wellness camps. Handheld ultrasound offers 99.11% sensitivity for pediatric pneumonia, surpassing chest X-ray and validating portable diagnostics鈥� clinical utility. Cart-based ultrasound and mobile DR units now include hotspot connectivity, funneling images to cloud PACS for instant reads.

Advances in battery density, wireless data transfer, and rugged casings have broadened deployment in disaster zones and sports medicine. Global Fund endorsements of portable X-ray solutions further legitimize the category. Over time, utilization of mobile scanners redeploys imaging load away from overburdened tertiary centers, expanding the India diagnostic imaging equipment market into new geographies while improving asset ROI.

By Application: Oncology Leadership, Cardiology Acceleration

Oncology captured 24.56% of the India diagnostic imaging equipment market in 2025 as multimodality imaging underpins every phase of cancer management. PET-CT fusion for metabolic mapping, diffusion-weighted MRI for response evaluation, and cone-beam CT for interventional procedures anchor purchasing decisions. Cardiology is set to log an 8.47% CAGR, tied to a 35.5% adult hypertension rate and rising CAD screening volume. High-temporal-resolution CT angiography, 3-D echocardiography, and cardiac MRI are gaining reimbursement traction, shifting procurement toward ECG-synchronized scanners.

Neurology rounds out high-growth niches as stroke protocols mandate sub-5-minute CT and perfusion imaging. Orthopedic centers invest in dual-energy CT for crystal arthropathy and low-dose trauma protocols. Gastroenterology leans on endoscopic ultrasound coupled with contrast-enhanced MRI for liver fibrosis staging. Such diversified clinical demand cements imaging as the diagnostic backbone across specialties, fortifying the India diagnostic imaging equipment market.

By End User: Hospital Dominance, Diagnostic Center Growth

Hospitals commanded 65.42% share of the India diagnostic imaging equipment market in 2025 because emergency rooms, surgical suites, and ICUs require on-premise scanners for real-time decisions. Diagnostic centers, though, are expanding at an 7.74% CAGR as urban patients prefer one-stop outpatient imaging with shorter waits and bundled wellness packages. Center chains leverage economies of scale to negotiate service contracts and centralized reporting, boosting uptime and reducing per-study costs.

Corporate preventive programs and telehealth triage funnel more routine scans to stand-alone facilities, freeing hospitals to focus on acute and interventional cases. Specialty clinics鈥攐rthopedics, cardiology, oncology鈥攁re adding in-house ultrasound and low-field MRI to expedite procedure planning. Together, these shifts diversify demand channels inside the India diagnostic imaging equipment market, encouraging vendors to tailor service models from enterprise-wide managed equipment services to pay-per-scan rentals.

Geography Analysis

South India led the India diagnostic imaging equipment market with 29.12% share in 2025, underpinned by high per-capita spend, dense medical college networks, and a robust medical tourism ecosystem. States like Karnataka and Tamil Nadu pioneer AI-embedded MRI installations and host manufacturing clusters benefiting from electronics supply chains. Regulatory compliance regimes are mature, enabling quicker installation certification and accelerating hybrid operating models that blend in-person and teleradiology workflows.

North India is the breakout growth engine, projected at a 8.72% CAGR through 2031, catalyzed by new AIIMS campuses and upgraded district hospitals funded by central schemes. Delhi-NCR functions as a hub for corporate insurance panels and attracts private equity into diagnostic center networks. Uttar Pradesh and Punjab drive volume through new cancer institutes and cath labs, while Haryana leverages proximity to the capital to launch PPP imaging suites. Still, workforce deficits necessitate aggressive adoption of AI pre-reads and cross-state teleradiology to meet burgeoning scan loads.

West India posts steady expansion anchored by Maharashtra鈥檚 specialty hospitals and Gujarat鈥檚 device manufacturing corridors. Pharmaceutical R&D in these states bolsters demand for pre-clinical imaging. East and North-East India trail on penetration but present white-space potential as infrastructure grants upgrade secondary hospitals. Improved air connectivity and government viability-gap funding are expected to unlock latent demand, gradually enlarging the geographic footprint of the India diagnostic imaging equipment market.

Regulatory Landscape

India regulates diagnostic imaging equipment as medical devices under the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017 (MDR 2017), with the Central Drugs Standard Control Organization (CDSCO) and the Drugs Controller General of India acting as the central licensing authority through a risk-based device classification framework. For radiology installations, compliance extends beyond device licensing to site and radiation-safety requirements where applicable (notably for X-ray systems). Importers and manufacturers must also follow the MDR 2017 documentation requirements and post-market obligations administered through CDSCO.

In April 2026, the Ministry of Health and Family Welfare issued a draft Medical Devices (Amendment) Rules, 2026 notification (G.S.R. 270(E)), indicating continued refinement of expectations around testing and traceability for devices supplied into India. The Department of Pharmaceuticals has also continued industrial-policy actions under Make in India, including a June 2026 review of the Global Tender Enquiry (GTE) exemption list, which can affect public procurement access for imported high-end imaging systems when domestic alternatives are being emphasized.

Value Chain Analysis

The India diagnostic imaging equipment value chain spans (i) upstream components and critical inputs (detectors, high-end electronics, tubes, and, for MRI, helium-related dependencies), (ii) OEM design, manufacturing/assembly, and quality systems, (iii) import and channel partners, (iv) installation, shielding and site readiness (particularly for CT and MRI suites), and (v) service, upgrades, consumables, and software (PACS, AI applications) that generate lifecycle revenue. While India has historically relied heavily on imports for high-technology imaging platforms, localization has progressed through the Production Linked Incentive (PLI) scheme, with manufacturing commenced for CT scanners, MRI machines, C-arm X-ray machines, mammography systems, and ultrasound equipment under the program.

Distribution and deployment depend on hospital procurement decisions, diagnostic center networks, and PPP structures that place scanners into district facilities, with service uptime, remote diagnostics, and application training acting as differentiators. Infrastructure enablers such as the Andhra Pradesh MedTech Zone (AMTZ) offer plug-and-play manufacturing facilities and common testing infrastructure, which can reduce entry barriers for domestic manufacturers. At the same time, compliance remains multi-layered for imaging suppliers (CDSCO under MDR 2017, and additional licensing for X-ray equipment under the Atomic Energy Regulatory Board), making regulatory affairs, calibration, and after-sales field service capabilities important across the chain.

Market Opportunities and Future Outlook

A primary opportunity set sits where localization and upgrade-driven replacement demand intersect: the PLI-backed manufacturing base, together with government emphasis on prioritizing indigenous production of high-value categories (including MRI components and X-ray systems referenced in June 2026 policy discussions), creates room for locally built configurations, component ecosystems, and India-specific service models. With equipment and procedure costs still constraining adoption, offerings that reduce total cost of ownership (including sealed-magnet or helium-light MRI platforms, remote service diagnostics, and pay-per-scan arrangements) can broaden addressable demand across hospitals and diagnostic imaging centers, especially beyond the top metros.

Another opportunity involves capacity expansion in oncology and advanced diagnostics backed by ongoing projects and institutional partnerships. In February 2026, IBA and Shreeji signed a multi-site agreement for four cyclotrons across Ahmedabad, Nagpur, Kochi, and Bhubaneswar, strengthening PET radiopharmaceutical availability and supporting PET-CT utilization beyond a limited number of tertiary hubs. Provider-side network build-outs also indicate equipment pull-through in Tier-I and Tier-II markets, including the October 2025 Superhealth and United Imaging partnership for supply and lifecycle management of radiology systems across 100 hospitals, and the March 2025 Aarthi Scans investment in Siemens helium-free MRI technology across multiple Indian cities, both pointing to demand for higher-throughput, digitally integrated imaging workflows.